In November 2023, Selecta Biosciences Inc. (NASDAQ: SELB) merged with Cartesian Therapeutics to create a publicly traded company pioneering RNA cell therapy to treat autoimmune disease. The combined company will focus on advancing Cartesian’s wholly owned pipeline, including Descartes-08, Cartesian’s clinical-stage lead product candidate being evaluated in patients with myasthenia gravis and other autoimmune diseases. For more information about the company and updates, please visit https://www.cartesiantherapeutics.com/ or follow us on LinkedIn @Cartesian-Therapeutics.
Company Details
- Employees
- 12
- Address
- 65 Grove Street, Watertown,ma 02472,united States
- Phone
- (617) 923-1400
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- selectabio.com
- HQ
- Watertown, MA
Selecta Biosciences Questions
Selecta Biosciences's helpline number is (617) 923-1400
Selecta Biosciences's website is selectabio.com
Selecta Biosciences's LinkedIn profile is https://www.linkedin.com/company/selecta-bio
Selecta Biosciences has
12 employees.
View email and phone details for 12
employees at Selecta Biosciences.
Selecta Biosciences's industry is
Biotechnology Research
Selecta Biosciences's top competitors are
Icell Gene Therapeutics,
Cartesian Therapeutics,
Alnylam Pharmaceuticals,
Tectonic Therapeutic, Inc.,
Arvinas,
Kyverna Therapeutics,
Morphic Therapeutic,
Beacon Therapeutics,
Intellia Therapeutics, Inc.,
Affini-T Therapeutics.
Selecta Biosciences's support email address is info@selectabio.com
Selecta Biosciences's categories are Biotechnology Research
